- Home
- LSB vs NVNO Comparison
LSB vs NVNO Comparison
Compare LSB & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSB
- NVNO
- Stock Information
- Founded
- LSB 2002
- NVNO 1987
- Country
- LSB China
- NVNO United States
- Employees
- LSB N/A
- NVNO N/A
- Industry
- LSB
- NVNO Medical/Dental Instruments
- Sector
- LSB
- NVNO Health Care
- Exchange
- LSB NYSE
- NVNO Nasdaq
- Market Cap
- LSB 49.8M
- NVNO 51.7M
- IPO Year
- LSB N/A
- NVNO N/A
- Fundamental
- Price
- LSB $2.51
- NVNO $2.57
- Analyst Decision
- LSB
- NVNO
- Analyst Count
- LSB 0
- NVNO 0
- Target Price
- LSB N/A
- NVNO N/A
- AVG Volume (30 Days)
- LSB 15.9K
- NVNO 125.2K
- Earning Date
- LSB 01-21-2025
- NVNO 10-31-2024
- Dividend Yield
- LSB N/A
- NVNO N/A
- EPS Growth
- LSB N/A
- NVNO N/A
- EPS
- LSB N/A
- NVNO N/A
- Revenue
- LSB $79,415,311.00
- NVNO N/A
- Revenue This Year
- LSB $39.33
- NVNO N/A
- Revenue Next Year
- LSB $75.61
- NVNO N/A
- P/E Ratio
- LSB N/A
- NVNO N/A
- Revenue Growth
- LSB N/A
- NVNO N/A
- 52 Week Low
- LSB $1.88
- NVNO $2.55
- 52 Week High
- LSB $11.20
- NVNO $6.97
- Technical
- Relative Strength Index (RSI)
- LSB 44.96
- NVNO 25.56
- Support Level
- LSB $2.10
- NVNO $2.90
- Resistance Level
- LSB $2.77
- NVNO $2.93
- Average True Range (ATR)
- LSB 0.36
- NVNO 0.17
- MACD
- LSB 0.01
- NVNO -0.03
- Stochastic Oscillator
- LSB 34.68
- NVNO 2.70
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).